145 related articles for article (PubMed ID: 37890590)
1. Generation of Non-Alloreactive Antiviral Central Memory CD8 Human Veto T Cells for Cell Therapy.
Bachar-Lustig E; Lask A; Eidelstein Y; Or-Geva N; Gidron-Budovsky R; Nathansohn-Levy B; Eyrich M; Liu WH; Dang G; Miranda KC; Ramirez A; Kaur I; Rezvani K; Shpall E; Champlin RE; Nagler A; Shimoni A; Barnees-Kagan S; Reisner Y
Transplant Cell Ther; 2024 Jan; 30(1):71.e1-71.e13. PubMed ID: 37890590
[TBL] [Abstract][Full Text] [Related]
2. Variances in Antiviral Memory T-Cell Repertoire of CD45RA- and CD62L-Depleted Lymphocyte Products Reflect the Need of Individual T-Cell Selection Strategies to Reduce the Risk of GvHD while Preserving Antiviral Immunity in Adoptive T-Cell Therapy.
Mangare C; Tischer-Zimmermann S; Bonifacius A; Riese SB; Dragon AC; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B
Transfus Med Hemother; 2022 Feb; 49(1):30-43. PubMed ID: 35221866
[TBL] [Abstract][Full Text] [Related]
3. Robust Identification of Suitable T-Cell Subsets for Personalized CMV-Specific T-Cell Immunotherapy Using CD45RA and CD62L Microbeads.
Mangare C; Tischer-Zimmermann S; Riese SB; Dragon AC; Prinz I; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30897843
[TBL] [Abstract][Full Text] [Related]
4. Antigenic competition in the generation of multi-virus-specific cell lines for immunotherapy of human cytomegalovirus, polyomavirus BK, Epstein-Barr virus and adenovirus infection in haematopoietic stem cell transplant recipients.
Roubalová K; Němečková Š; Kryštofová J; Hainz P; Pumannová M; Hamšíková E
Immunol Lett; 2020 Dec; 228():64-69. PubMed ID: 33031870
[TBL] [Abstract][Full Text] [Related]
5. Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis.
Teschner D; Distler E; Wehler D; Frey M; Marandiuc D; Langeveld K; Theobald M; Thomas S; Herr W
Bone Marrow Transplant; 2014 Jan; 49(1):138-44. PubMed ID: 23933765
[TBL] [Abstract][Full Text] [Related]
6. A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants.
Lucas KG; Sun Q; Burton RL; Tilden A; Vaughan WP; Carabasi M; Salzman D; Ship A
Hum Gene Ther; 2000 Jul; 11(10):1453-63. PubMed ID: 10910142
[TBL] [Abstract][Full Text] [Related]
7. MEK inhibitors selectively suppress alloreactivity and graft-versus-host disease in a memory stage-dependent manner.
Shindo T; Kim TK; Benjamin CL; Wieder ED; Levy RB; Komanduri KV
Blood; 2013 Jun; 121(23):4617-26. PubMed ID: 23575444
[TBL] [Abstract][Full Text] [Related]
8. Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells.
Tischer S; Priesner C; Heuft HG; Goudeva L; Mende W; Barthold M; Kloeß S; Arseniev L; Aleksandrova K; Maecker-Kolhoff B; Blasczyk R; Koehl U; Eiz-Vesper B
J Transl Med; 2014 Dec; 12():336. PubMed ID: 25510656
[TBL] [Abstract][Full Text] [Related]
9. The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT.
Or-Geva N; Reisner Y
Bone Marrow Transplant; 2015 Jun; 50 Suppl 2():S14-20. PubMed ID: 26039201
[TBL] [Abstract][Full Text] [Related]
10. Generation of alloreactivity-reduced donor lymphocyte products retaining memory function by fully automatic depletion of CD45RA-positive cells.
Müller N; Landwehr K; Langeveld K; Stenzel J; Pouwels W; van der Hoorn MAWG; Seifried E; Bonig H
Cytotherapy; 2018 Apr; 20(4):532-542. PubMed ID: 29500069
[TBL] [Abstract][Full Text] [Related]
11. Novel treatment of severe combined immunodeficiency utilizing ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation and CD45RA+ depleted donor lymphocyte infusions.
Brodszki N; Turkiewicz D; Toporski J; Truedsson L; Dykes J
Orphanet J Rare Dis; 2016 Jan; 11():5. PubMed ID: 26768987
[TBL] [Abstract][Full Text] [Related]
12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
13. Optimization of methodology for production of CD25/CD71 allodepleted donor T cells for clinical use.
Albon SJ; Mancao C; Gilmour K; White G; Ricciardelli I; Brewin J; Lugthart G; Wallace R; Amrolia PJ
Cytotherapy; 2013 Jan; 15(1):109-21. PubMed ID: 23260091
[TBL] [Abstract][Full Text] [Related]
14. Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses.
Amrolia PJ; Muccioli-Casadei G; Yvon E; Huls H; Sili U; Wieder ED; Bollard C; Michalek J; Ghetie V; Heslop HE; Molldrem JJ; Rooney CM; Schlinder J; Vitetta E; Brenner MK
Blood; 2003 Sep; 102(6):2292-9. PubMed ID: 12763937
[TBL] [Abstract][Full Text] [Related]
15. CD38
Khandelwal P; Chaturvedi V; Owsley E; Lane A; Heyenbruch D; Lutzko CM; Leemhuis T; Grimley MS; Nelson AS; Davies SM; Jordan MB; Marsh RA
Biol Blood Marrow Transplant; 2020 Jan; 26(1):1-6. PubMed ID: 31442594
[TBL] [Abstract][Full Text] [Related]
16. Human CD8+ memory and EBV-specific T cells show low alloreactivity in vitro and in CD34+ stem cell-engrafted NOD/SCID/IL-2Rγc null mice.
Thomas S; Klobuch S; Sommer M; van Ewijk R; Theobald M; Meyer RG; Herr W
Exp Hematol; 2014 Jan; 42(1):28-38.e1-2. PubMed ID: 24120693
[TBL] [Abstract][Full Text] [Related]
17. Large-scale preparation of human anti-third-party veto cytotoxic T lymphocytes depleted of graft-versus-host reactivity: a new source for graft facilitating cells in bone marrow transplantation.
Aviner S; Yao X; Krauthgamer R; Gan Y; Goren-Arbel R; Klein T; Tabilio A; McMannis JD; Champlin R; Martelli MF; Bachar-Lustig E; Reisner Y
Hum Immunol; 2005 Jun; 66(6):644-52. PubMed ID: 15993710
[TBL] [Abstract][Full Text] [Related]
18. Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings.
Davies JK; Koh MB; Lowdell MW
Biol Blood Marrow Transplant; 2004 Apr; 10(4):259-68. PubMed ID: 15077224
[TBL] [Abstract][Full Text] [Related]
19. Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation.
Lugthart G; van Ostaijen-Ten Dam MM; Jol-van der Zijde CM; van Holten TC; Kester MG; Heemskerk MH; Bredius RG; van Tol MJ; Lankester AC
Biol Blood Marrow Transplant; 2014 May; 20(5):655-61. PubMed ID: 24462981
[TBL] [Abstract][Full Text] [Related]
20. Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose.
Bachar-Lustig E; Reich-Zeliger S; Reisner Y
Blood; 2003 Sep; 102(6):1943-50. PubMed ID: 12775573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
